Atlas Trials

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Clinical trial NCT03650933 · UNKNOWN

Trial details

NCT number
NCT03650933
Sponsor
Nanjing Yoko Biomedical Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma, Unspecified Site
Start date
2018-12-28
Primary completion
2022-08-17
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.